Marchalonis J J, Schwabe C, Gersten D M, Hearing V J
Biochem Biophys Res Commun. 1984 May 31;121(1):196-202. doi: 10.1016/0006-291x(84)90706-x.
Melanoma tumors express both common antigenic determinants and individually specific markers. A melanoma-specific glycoprotein antigen ( B700 ) with a molecular weight of approximately 65,000 daltons was detected on murine B16 melanoma cells but appears on other murine and human melanoma tumors. In order to determine the relationship between the B700 antigen and other melanoma antigens which have been described and to elucidate molecular changes that have taken place in the transformation from melanocyte to melanoma, we have purified the B700 glycoprotein to homogeneity. We have carried out amino acid composition analysis and partial sequence determinations and report that the B700 melanoma antigen shows similarities to serum albumin, but is not identical to this normal component. Moreover, amino-terminal variation occurs in the first 15 residues of the B700 antigen produced by separate B16 tumors.
黑色素瘤肿瘤表达共同的抗原决定簇和个体特异性标志物。在鼠B16黑色素瘤细胞上检测到一种分子量约为65,000道尔顿的黑色素瘤特异性糖蛋白抗原(B700),并且在其他鼠类和人类黑色素瘤肿瘤上也有出现。为了确定B700抗原与已描述的其他黑色素瘤抗原之间的关系,并阐明从黑素细胞转变为黑色素瘤过程中发生的分子变化,我们已将B700糖蛋白纯化至同质。我们进行了氨基酸组成分析和部分序列测定,并报告B700黑色素瘤抗原与血清白蛋白有相似之处,但与这种正常成分并不相同。此外,由不同的B16肿瘤产生的B700抗原在其前15个残基处存在氨基末端变异。